Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration
文献类型：期刊论文
| 作者 | Zhang, Dadong1,3; Wu, Heming2; Zhang, Xiaomin2; Ding, Xu2; Huang, Min1,3 ; Geng, Meiyu1,3; Li, Hongwei2; Xie, Zuoquan1,3
|
| 刊名 | JOURNAL OF CANCER
 |
| 出版日期 | 2017 |
| 卷号 | 8期号:11页码:1943-1951 |
| 关键词 | Oral cancer Phosphoglycerate mutase 1 Migration Prognosis SRC |
| ISSN号 | 1837-9664 |
| DOI | 10.7150/jca.19278 |
| 文献子类 | Article |
| 英文摘要 | Oral squamous cell carcinoma (OSCC) is a common malignant tumor with high metastatic potential. However, no good biomarker has been identified to refine which subtype is of high metastatic potential to make decisions regarding the elective and therapeutic management of lymphatic metastases. In this study, we investigated the role of the metabolic enzyme phosphoglycerate mutase 1 (PGAM1) in OSCC. PGAM1 expression was examined in tissue samples of 122 OSCC patients using immunohistochemistry, and the correlation between clinicopathological expression and PGAM1 expression was determined. Survival curves were generated using the Kaplan-Meier method, and multivariate analysis was performed by the Cox proportional hazards model. Moreover, PGAM1 was knocked down in the OSCC cell lines Cal27 and HN12, followed by determination of the change in cell migration and signaling pathways. PGAM1 expression is correlated with age, lymphatic metastasis and tumor recurrence and is closely associated with poor overall survival (OS) and disease-free survival (DFS). Intriguingly, PGAM1 is an independent risk factor for OS and DFS. After knocking down PGAM1 in Cal27 and HN12 cells, cell migration was remarkably decreased along with signaling pathway molecules, such as proto-oncogene c-SRC (SRC), Focal adhesion kinase (FAK) and Paxillin. The effect on cell migration was abolished following pretreatment with an SRC inhibitor. This study suggested that PGAM1 is a poor prognostic biomarker of OSCC and may be used to select patients of high metastatic potential in the clinic, and PGAM1 promotes the migration of OSCC cells is associated with the SRC pathway. |
| WOS关键词 | PYRUVATE-KINASE M2 ; CANCER ; LUNG ; DISCOVERY ; GROWTH |
| 资助项目 | National Natural Science Foundation of China[81202549] ; "Personalized Medicines-- Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020341] |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000406938500002 |
| 出版者 | IVYSPRING INT PUBL |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/275704]  |
| 专题 | 药理学第一研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Li, Hongwei; Xie, Zuoquan |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Anti Tumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China; 2.Nanjing Med Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp Stomatol, Jiangsu Key Lab Oral Dis, Nanjing 210029, Jiangsu, Peoples R China; 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhang, Dadong,Wu, Heming,Zhang, Xiaomin,et al. Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration[J]. JOURNAL OF CANCER,2017,8(11):1943-1951. |
| APA | Zhang, Dadong.,Wu, Heming.,Zhang, Xiaomin.,Ding, Xu.,Huang, Min.,...&Xie, Zuoquan.(2017).Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration.JOURNAL OF CANCER,8(11),1943-1951. |
| MLA | Zhang, Dadong,et al."Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration".JOURNAL OF CANCER 8.11(2017):1943-1951. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。